Optimizing the Drug Supply Strategy

Discover how a Sponsor optimized the drug delivery via IDDI’s Proposition of a Predictive Drug Supply Model.

PLEASE FILL IN THE FORM TO ACCESS THE CASE STUDY

SITUATION:

  • Phase II
  • Efficacy assessment of a new drug in combination with an antibody in patients with advanced triple negative breast cancer
  • Expensive drug to manufacture
  • Different compositions for both Placebo and Active drugs:
    • 5 mg vials
    • 3 mg vials
    • 2 mg vialsIn case of an event, drug dose reduction occurs
  • Difficult to predict 3 mg and 2 mg drug allocations
  • Usage of central pharmacies

SPONSOR’S REQUEST:
Optimize the drug delivery (limit the quantity of shipped vials yet assure sufficient vials are on site).

Discover our RTSM Solution

  • Do you have a question ?
  • Call us on Tel.: +32 (0) 10 61 44 44 ( IDDI Head Office) or  Tel.: +1 984 227 8599 (US Headquarters)
Contact us
Optimizing the Drug Supply Strategy